For Patients

Chronic Infammatory
Demyelinating Polyneuropathy

The term Chronic inflammatory demyelinating polyneuropathy (CIDP) has been used to identify patients with a chronically progressive or relapsing symmetric sensorimotor disorder with cytoalbuminologic dissociation and interstitial and perivascular endoneurial infiltration by lymphocytes and macrophages. It can be considered the chronic equivalent of acute inflammatory demyelinating polyradiculoneuropathy, the most common form of Guillain-Barré syndrome. CIDP typically starts insidiously and evolves slowly, in either a slowly progressive or a relapsing manner, with partial or complete recovery between recurrences; periods of worsening and improvement usually last weeks or months. Most experts consider the necessary duration of symptoms to be greater than 8 weeks for the diagnosis of CIDP to be made. Pertinent physical findings are limited to the nervous system, except when the condition is associated with other diseases.


Immune Globulin Therapy Corticosteroids

More Information

For more information, please visit the CIDP-GBS Foundation International at
20% of CSI Pharmacy patients have CIDP.

Products We Offer

Immune Globulin Therapy


Contact CSI Pharmacy for more information on Corticosteroids.

Ask a CSI Pharmacy Expert about CIDP